Metlife Inc

Metlife Inc

MET

Get informed when a big investor buys or sells

+ Follow
Market Cap$55.07B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Metlife IncMetlife Inc15.42.68%13%0.70.7

Earnings Call Q1 2026

May 7, 2026 - AI Summary

Strong start to 2026 / “New Frontier” execution (good + surprising) - Adjusted earnings: $1.6B (+18% YoY) or $2.42/share (+23% YoY)—EPS growth outpaced earnings growth, reflecting disciplined capital management. - Adjusted premiums/fees & other revenues (ex pension risk transfers): +10% YoY, with broad-based growth across businesses/regions. - Adjusted ROE: 17% (top of 15–17% target range, well above cost of capital). - Expense discipline: Direct expense ratio 11.9%, improving vs last year and ahead of full-year target (they beat the 12.1% annual target).
Investment performance and variable income outlook (good, with some quarter-specific headwinds) - Pretax variable investment income (VII): $518M, third straight quarter above expectation, driven by private equity returns ~2.9% aided by strong venture capital. - Core vs total spread: total RIS investment spread 119 bps at top end of 100–120 bps guidance; core spread ex VII ~95 bps and down ~4 bps sequentially due to asset rotations from large Q4 inflows (esp. PRT-related flows). - RIS full-year guidance reaffirmed: expected full-year adjusted earnings $1.6B–$1.8B. - Q2 expectation: core spreads ~flat to modestly improved; total spreads continue to track full-year range, but flat yield curve / short-end higher remains a mild headwind.
Business momentum by segment (good + opportunities) - Group Benefits: $439M adjusted earnings (+19% YoY); sales +15%, adjusted PFOs +4%; working-age mortality exceptional (life mortality ratio 80.1% vs 2026 target range 83–88%). Persistency remains strong (persistency high 90s, tenure >20 years). - Retirement & Income Solutions (RIS): $451M (+11% YoY); $1.5B new sales (including UK-funded reinsurance and retail annuity reinsurance). - Asia: $487M (+31%); sales +22% constant currency—Japan sales +26% CC, Korea +44% CC; they cited new product traction and strong distribution. - EMEA: $110M (+33%), with adjusted PFOs +15% CC and sales +17% CC—reflecting multi-year shift toward capital-light A&H and life.

Exclusive for Stockcircle Pro members

Sign upSign Up
$94.13

Target Price by Analysts

6.9% upsideMetlife Target Price DetailsTarget Price
$213.87

Current Fair Value

142.9% upside

Undervalued by 142.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$55.07 Billion
Enterprise Value$52.67 Billion
Dividend Yield$2.29 (2.68%)
Earnings per Share$4.8
Beta0.78
Outstanding Shares652,000,000

Return

Return on Equity13.11%ROE
Return on Assets0.48%
Return on Invested Capital0.79%

Valuation & Multiples

P/E Ratio15.42P/E Ratio
PEG60.71PEG
Price to Sales0.74Price to Sales
Price to Book Ratio2.1Price to Book Ratio
Enterprise Value to Revenue0.68
Enterprise Value to EBIT8.95
Enterprise Value to Net Income14
Total Debt to Enterprise0.39
Debt to Equity0.74Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 6, 2026
EPS Estimate
$2.27
Average shareholder expectation
Revenue Estimate
$19.49 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$2.39
Average shareholder expectation
Revenue Estimate
$19.77 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.5645▲ 51.37%
Total Calls2,949,319▼ 30.78%
Total Puts4,614,290▲ 3.06%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %72.63%▼ 1.27%
Total Invested$34.14B▼ 11.95%
Investors Holding1,429▼ 67.00%

ESG Score

No data

About Metlife Inc

46,500 employees
CEO: Michel Khalaf

MetLife, Inc., through its subsidiaries and affiliates ('MetLife'), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institution...

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the official revenue estimates and technical analysis for all tax legislation. Its work directly influences corporate tax structures, capital investment incentives, and the overall tax burden on financial markets, which is critical for MetLife's financial planning and profitability.

Finance

This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Its decisions on corporate tax policy directly impact MetLife's profitability, global trade rules affect its international operations, and entitlement spending shapes the healthcare and retirement landscapes.

Health, Education, Labor, and Pensions

This committee directly regulates labor laws, pensions (ERISA), and aspects of healthcare. These areas are central to MetLife's employee benefits segment, including health insurance, retirement plans, and group benefits offerings.

Banking, Housing, and Urban Affairs

This committee is a primary regulator of the entire financial system, including the Fed and SEC. It directly impacts bank capital requirements, cryptocurrency regulation, and real estate markets, all of which are critical for MetLife's asset management, institutional investments, and financial solvency.

Foreign Relations

MetLife operates in over 40 global markets. This committee's actions on sanctions, foreign policy, and international banking access directly impact MetLife's international operations, investment strategies, and overall global market risk.